Navigation Links
NeurogesX to Present at Needham Life Sciences Conference
Date:6/3/2009

r materially due to various risks and uncertainties, including, but not limited to; positive results in clinical trials may not be sufficient to obtain FDA approval; any regulatory approvals which are received may be limited to certain indications; NeurogesX' product candidates may have unexpected adverse side effects or inadequate therapeutic efficacy physician or patient reluctance to use Qutenza or NGX-1998, if approved, or the inability of physicians to obtain sufficient reimbursement for such procedures; potential alternative therapies; maintaining adequate patent or trade secret protection without violating the intellectual property rights of others; and other difficulties or delays in, clinical development, obtaining regulatory approval, market acceptance and commercialization of NeurogesX' product candidates and the advantages of NeurogesX' product candidates over other pain therapies. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission. 

    NeurogesX, Inc.            The Ruth Group
    Stephen Ghiglieri          Sara Pellegrino (investors)
    Chief Financial Officer    (646) 536-7002
    (650) 358-3310             spellegrino@theruthgroup.com

                               Jason Rando (media)/Janine McCargo
                               (646) 536-7025/7033
                               jrando@theruthgroup.com
                               jmccargo@theruthgroup.com


'/>"/>
SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. NeurogesX Receives European Commission Approval for Qutenza(TM)
2. NeurogesX Reports First Quarter 2009 Results
3. NeurogesX to Hold Conference Call to Discuss First Quarter 2009 Financial Results
4. NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting
5. NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update
6. NeurogesX Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
7. NeurogesX to Present at 11th Annual BIO CEO & Investor Conference
8. NeurogesX to Present at Rodman & Renshaw 10th Annual Healthcare Conference
9. NeurogesX Reports Third Quarter 2008 Results
10. NeurogesX to Report Third Quarter 2008 Financial Results
11. NeurogesX Submits NDA for NGX-4010 Dermal Capsaicin Patch for Treatment of Postherpetic Neuralgia (PHN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... FL (PRWEB) May 20, 2013 Researchers from ... in the connection between lower back pain, and the acne ... P.acnes in the system the bacteria seek out oxygen deprived ... incurred in the spinal column, P.acnes has the ability to ... , Fernando Perez, a spokesman for “ The best ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 In Early ... the field of biotoxin related illnesses , announced his ... country able to advance his protocol for treating Chronic ... became the third physician to achieve certification in the ... Physicians, able to practice the Shoemaker Protocol in other ...
(Date:5/17/2013)... Topricin Pain Relief and Healing ... listed among nationally recommended over-the-counter (OTC) health products ... "U.S. News" Health in collaboration with "Pharmacy Times." ... 1 Pharmacists Recommended designation” in the “Topical Analgesics” ... and is the only homeopathic formula to earn ...
(Date:5/17/2013)... German . Photographers ... you can see which branch a bird is sitting on, ... the telephoto lens for high-magnification images requires considerable skill. It ... study proteins, the active biomolecules of cells. , Olga Schubert, ... Biology, and her colleagues have now come up with a ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares New Insight How Treating Acne May Help Reduce Body Pain 2Dr. Ritchie Shoemaker Certifies Third Physician in His Treatment Protocol for Chronic Inflammatory Response Syndrome (CIRS) 2Pharmacists' Picks: Topical BioMedics' Topricin Listed on Top Recommended OTC Health Products 2Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3
... NEW YORK, June 20, 2011 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p0558644/The-Cancer-Market-Outlook-to-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... global cancer market is becoming increasingly competitive, ...
... Park, MD (June 17, 2011)--A team of researchers has proposed ... enabling it to control the flow of electrons with a ... ever discovered. It,s a layer of carbon atoms only one-atom ... electricity extremely well and heat better than any other known ...
... International Inc. (Nasdaq: KNDL ) ("Kendle"), announced ... for its cash tender offer and consent solicitation for ... amount of outstanding 3.375% Convertible Senior Notes due 2012 ... consideration for each $1,000.00 principal amount of Notes validly ...
Cached Biology Technology:Reportlinker Adds The Cancer Market Outlook to 2016 2Reportlinker Adds The Cancer Market Outlook to 2016 3Reportlinker Adds The Cancer Market Outlook to 2016 4Reportlinker Adds The Cancer Market Outlook to 2016 5Graphene may gain an 'on-off switch,' adding semiconductor to long list of material's achievements 2Kendle International Inc. Increases Consideration Amount for Tender Offer and Consent Solicitation for Convertible Notes 2Kendle International Inc. Increases Consideration Amount for Tender Offer and Consent Solicitation for Convertible Notes 3Kendle International Inc. Increases Consideration Amount for Tender Offer and Consent Solicitation for Convertible Notes 4
(Date:5/17/2013)... all ages will celebrate the science and technology ... daily lives during the inaugural Atlanta Science Festival, ... from local museums, corporations, K-12 schools and universities, ... events for children and adults at venues across ... , The annual Atlanta Science Festival is ...
(Date:5/17/2013)... Bethesda, MD The Federation of American Societies for ... of National Institutes of Health (NIH) funding trends highlighting ... to support critical research. The FASEB analysis follows a ... Francis Collins, MD, PhD, who testified that the $1.6 ... to sequestration is "having a substantial impact on the ...
(Date:5/16/2013)... fast food restaurant had a higher body mass index ... food, according to researchers at The University of Texas ... strong among those with a lower income. , ... Journal of Public Health indicates higher BMI associates ... among lower-income African-Americans, the density, or number, of fast ...
Breaking Biology News(10 mins):First Atlanta Science Festival set for 2014 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3
... the brain which, if used artificially, may prevent brain damage ... By looking at what happens in the brain after ... a key molecule, ,KCC2, causes brain cell death after an ... 2011) in The Journal of Physiology now opens ...
... The human brain has yet to explain the origin of ... that increase its surface area and allow for rational and ... Yale School of Medicine and Turkey may have discovered humanity,s ... determines the formation of brain convolutions they report online ...
... has signed an exclusive license agreement with Westfalia ... ,GEM, an avocado variety developed by UC Riverside researchers. ... Westfalia will be UC Riverside,s primary licensee for ,GEM, ... the Californiabased Brokaw Nursery has non-exclusive rights to the ...
Cached Biology News:New understanding of brain chemistry could prevent brain damage after injury 2Tiny variation in 1 gene may have led to crucial changes in human brain 2UC Riverside licenses leading South African company to market 'GEM' avocados 2UC Riverside licenses leading South African company to market 'GEM' avocados 3
Recorder, 6", 7 Day, 1 Pen, 0 to 100°C, 220V, 50/60 Hz, for 4520, Customer Installed...
... The Pro upgrade for Shimadzu Phoretix 2D, ... advanced statistical tools for comparative gel analysis ... Data base add on component ... (Oracle version 9i release 2 client software). ...
6B9...
... Recombinant DNA polymerase from Thermus aquaticus ... DNA contamination; 1 tube of 250 units ... LD (Low DNA), is the same enzyme ... purified through a proprietary separation process to ...
Biology Products: